APA (7th ed.) Citation

Moore, A. S., Faisal, A., Mak, G. W., Miraki-Moud, F., Bavetsias, V., Valenti, M., . . . Linardopoulos, S. (2020). Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736. Blood Advances, 4(7), 1478-1491. https://doi.org/10.1182/bloodadvances.2019000986

Chicago Style (17th ed.) Citation

Moore, Andrew S., et al. "Quizartinib-resistant FLT3-ITD Acute Myeloid Leukemia Cells Are Sensitive to the FLT3-Aurora Kinase Inhibitor CCT241736." Blood Advances 4, no. 7 (2020): 1478-1491. https://doi.org/10.1182/bloodadvances.2019000986.

MLA (8th ed.) Citation

Moore, Andrew S., et al. "Quizartinib-resistant FLT3-ITD Acute Myeloid Leukemia Cells Are Sensitive to the FLT3-Aurora Kinase Inhibitor CCT241736." Blood Advances, vol. 4, no. 7, 2020, pp. 1478-1491, https://doi.org/10.1182/bloodadvances.2019000986.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.